BLACK CYBER WEEK! Publikacje i multimedia nawet do 80% taniej i darmowa dostawa od 350 zł! Sprawdź >
4. Rozpoznanie przyczyny zaburzeń psychiatrycznych (zapalenie, niedokrwienie, leki) jest podstawą włączenia właściwego leczenia przyczynowego, które powinno być uzupełnione objawową terapią psychiatryczną.
Piśmiennictwo
1. Dantzer R, Kelly KW. Twenty years of research on cytokine – induced sickness behavior. Brain Behav Immun 2007;21:441-460
2. Petri M, Orbai A M, Alarco’n GS i wsp. Derivation and Validation of the Systemic Lupus International Collaborating Clinics Classification Criteria for Systemic Lupus Erythematosus Arthritis & Rheum 2012;64:2677-2686
3. The American College of Rheumatlogy nomenclature and case definitions for neuropsychiatric lupus syndromes. Arth Rheum 1999;42:599-608
4. Hajduk A, Smoleńska Ż, Nowicka-Sauer K, Zdrojewski Z. Zespoły neuropsychiatryczne u chorych na toczeń rumieniowaty układowy. Reumatologia 2012;50(6):493-500
5. Su D, Liu R, Li X, Sun L. Possible novel biomarkers of organ involvement in systemic lupus erythematosus. Clin Rheum 2014;33(8):1025-31
6. Hanly JG. Diagnosis and management of neuropsychiatric SLE. Nature Rev Rheum 2014;10:338-347
7. Tomietto P, Annese V, D’agostini S i wsp. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Arthritis Rheum 2007;57:1461-1472
8. Bertsias GK, Ioannidis JP, Aringer M i wsp. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis 2010;69:2074-2082
9. Fanouriakis A, Boumpas DT, Bertasias GK. Pathogenesis and treatment of CNS Lupus. Curr Opin Rheum 2013;25:577-583
10. Asano NMJ, Coriolano MG, Asano BJ i wsp. Psychiatric comorbidities in patients with systemic lupus erythematosus: a systematic review of the last 10 years. Rev Bras Reumatol 2013;53:431-437
11. Zirkzee EJM, Steup-Beekman GM, Mast RC i wsp. Prospective study of clinical phenotypes in neuropsychiatric systemic lupus erythematosus; multidisciplinary approach to diagnosis and therapy. J Rheumatology 2012;39:2118-2126
12. Miyakis S, Lockshin MD, Atsumi T i wsp. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306
13. Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 2011;7:330-339
14. Brey RL, Muscal E, Chapman J. Antiphospholipd antibodies and the brain: A consensus report. Lupus 2011;20:153-157
15. Li ChH, Chou MCh, Liu ChK, Lai ChL. Antiphospholipid syndrome presenting as progressive neuropsychiatric disorders: two case reports. Neuropsychiatric Dis Treatment 2013;9:739-742
16. Matcham F, Rayner L, Steer S i wsp. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology 2013;52:2136-2148
17. Kwiatkowska B. Występowanie objawów depresji w powiązaniu z przebiegiem i obrazem klinicznym reumatoidalnego zapalenia stawów. Reumatologia 2011;49 suppl. 1:S11-S84 (rozprawa habilitacyjna)
18. Mura G, Krishna MB, Pisano A i wsp. Psychiatric symptoms and quality of life in systemic sclerosis. Clinical Practice & Epidem in Mental Health 2012;8:30-35
19. McNair S, Hategan A, Bourgeois JA i wsp. Neuropsychiatric symptoms in scleroderma. Psychosomatics 2013;54:382-386
20. Hyphantis TN, Tsifetaki N, Siafaka V i wsp. The impact of psychological functioning upon systemic sclerosis patients quality of life. Sem Arthritis Rheum 2007;37:81-92
21. Teixeira F, Silva AM, Vasconcelos C i wsp. Neurological involvement in primary Sjőgren syndrome. Acta Reumatol Port 2013;38:29-36
22. Morreale M, Marchione P, Giacomini P i wsp. Neurological involvement in primary Sjőgren syndrome: A focus on central nervous system. PLOS one 2014;9:e84605
23. Tezuka T, Azuma M, Goto H i wsp. Psychiatric symptoms in a patient with Churg-Strauss syndrome. Intern Med 2012;51:301-303
24. Basu N, Mc Clean A, Harper L i wsp. Explaining fatigue in ANCA-associated vasculitis. Rheumatol 2013;52:1680-1685
25. Yilmaz N, Can M, Oner FA i wsp. Impaired quality of life, disability and mental health in Takayasu arteritis. Rheumatol 2013;52:1898-1904
26. Kumar B, Toney DE, Alikhan M i wsp. Giant cell arteritis presenting as depressed mood and headache in an elderly patient. J Clin Rheumatol 2013;19:405-406
27. Hajj-Ali R, Calabrese LH. Primary angiitis of the central nervous system. Autoimmunity Rev 2013;12:463-466
28. Salvarani C, Brown RD, Hunder GG. Adult primary central nervous system vasculitis. Lancet 2012;380:767-777
29. Bhangle SD, Kramer N, Rosenstein ED. Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus. Rheumatol Int 2013;33:1923-1932
30. Dixon R, Christy N. On the various forms of corticosteroid withdrawal syndrome. Am J Med 1980;68:224-230